Reasons for Arnold Steiner’s Shares Sale of Old Republic International (ORI)’s Stock; Shorts at Cytosorbents (CTSO) Raised By 1.76%

June 14, 2018 - By Peter Erickson

Cytosorbents Corporation (NASDAQ:CTSO) Logo

Cytosorbents Corporation (NASDAQ:CTSO) had an increase of 1.76% in short interest. CTSO’s SI was 1.51M shares in June as released by FINRA. Its up 1.76% from 1.48M shares previously. With 181,100 avg volume, 8 days are for Cytosorbents Corporation (NASDAQ:CTSO)’s short sellers to cover CTSO’s short positions. The SI to Cytosorbents Corporation’s float is 6.49%. The stock decreased 2.61% or $0.3 during the last trading session, reaching $11.2. About 167,220 shares traded. Cytosorbents Corporation (NASDAQ:CTSO) has risen 156.32% since June 14, 2017 and is uptrending. It has outperformed by 143.75% the S&P500. Some Historical CTSO News: ; 28/03/2018 – CytoSorbents Reports on the Successful 5th International CytoSorb Users Meeting and 38th ISICEM Critical Care Conference; 08/03/2018 – CYTOSORBENTS CORP CTSO.O : COWEN AND COMPANY RAISES TARGET PRICE TO $9 FROM $7; 23/03/2018 – CytoSorbents Access Event Set By LifeSci Advisors for Mar. 28; 08/03/2018 – Cytosorbents 2017 Loss/Shr 32c; 08/05/2018 – CYTOSORBENTS CORP – EXPECT SECOND QUARTER 2018 PRODUCT SALES TO EXCEED PRODUCT SALES REPORTED IN THE FIRST QUARTER OF 2018; 22/05/2018 – CytoSorbents Presenting at Conference Tomorrow; 28/03/2018 – CytoSorbents at Non-Deal Roadshow Hosted By LifeSci Advisors; 04/05/2018 – New Research: Key Drivers of Growth for Lincoln Electric, Cytosorbents, Materion, Fortune Brands Home & Security, Washington Re; 09/04/2018 – CytoSorbents Presenting at Conference Apr 9; 17/05/2018 – CYTOSORBENTS CORP CTSO.O : COWEN AND COMPANY RAISES TARGET PRICE TO $11 FROM $9

Investors sentiment decreased to 1.5 in 2018 Q1. Its down 0.13, from 1.63 in 2017Q4. It turned negative, as 24 investors sold Old Republic International Corporation shares while 101 reduced holdings. 70 funds opened positions while 118 raised stakes. 219.70 million shares or 16.14% more from 189.18 million shares in 2017Q4 were reported. Natl Bank Of Hawaii holds 0.02% or 11,045 shares in its portfolio. The Georgia-based Advisory Networks has invested 0.03% in Old Republic International Corporation (NYSE:ORI). Pggm Investments holds 0.01% of its portfolio in Old Republic International Corporation (NYSE:ORI) for 101,282 shares. 17,421 were accumulated by Hilltop Incorporated. Baystate Wealth Limited Com has 10 shares for 0% of their portfolio. Aperio Ltd Liability accumulated 396,295 shares. Wespac Advisors Limited Liability holds 0.64% of its portfolio in Old Republic International Corporation (NYSE:ORI) for 48,753 shares. American Financial Bank has 603 shares for 0% of their portfolio. Employees Retirement System Of Texas stated it has 228,000 shares or 0.07% of all its holdings. Gotham Asset Management Llc has invested 0% in Old Republic International Corporation (NYSE:ORI). Mesirow Invest Mngmt holds 0.19% or 90,935 shares. Rodgers Brothers Inc, Pennsylvania-based fund reported 95,806 shares. Tower Cap Lc (Trc) holds 0.04% or 19,437 shares. First Manhattan Company holds 0.32% of its portfolio in Old Republic International Corporation (NYSE:ORI) for 2.64 million shares. Convergence Partners Ltd Liability Company invested in 215 shares.

Analysts await Old Republic International Corporation (NYSE:ORI) to report earnings on July, 26. They expect $0.40 EPS, up 17.65% or $0.06 from last year’s $0.34 per share. ORI’s profit will be $120.08 million for 13.23 P/E if the $0.40 EPS becomes a reality. After $0.40 actual EPS reported by Old Republic International Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

The stock increased 0.24% or $0.05 during the last trading session, reaching $21.16. About 4.63M shares traded or 145.02% up from the average. Old Republic International Corporation (NYSE:ORI) has risen 12.48% since June 14, 2017 and is uptrending. It has underperformed by 0.09% the S&P500. Some Historical ORI News: ; 30/05/2018 – Old Republic Announces Formation Of A New Residual Market Services Entity; 07/05/2018 – FRUTAROM CEO ORI YEHUDAI WILL SERVE AS ADVISOR; 26/04/2018 – OLD REPUBLIC 1Q NET INCOME 1C/SHR; 21/03/2018 – Old Republic Is Liability Insurer for Uber’s Self-Driving Cars; 25/04/2018 – A.M. Best Affirms Credit Ratings of Subsidiaries of Old Republic International Corporation; 26/04/2018 – OLD REPUBLIC INTERNATIONAL CORP QTRLY NET PREMIUMS AND FEES EARNED $1,330.4 MLN VS $1,301.0 MLN; 16/05/2018 – Ori Announces Availability for Commercial Developers in Greater Boston, New York Metropolitan Area, and Washington, D.C; 14/03/2018 – OLD REPUBLIC INTL CORP FILES MIXED SECURITIES SHELF; 16/04/2018 – Hamlin Capital Buys New 1.1% Position in Old Republic; 26/04/2018 – OLD REPUBLIC INTERNATIONAL CORP – QTRLY NET INCOME $4.0 MLN VS $113.1 MLN

Since February 15, 2018, it had 2 buys, and 3 selling transactions for $1.41 million activity. The insider REED GLENN W bought $102,150. Shares for $480,375 were sold by LEROY SPENCER III. ZUCARO ALDO C had bought 80 shares worth $1,609 on Wednesday, March 7. $511,240 worth of Old Republic International Corporation (NYSE:ORI) shares were sold by BOONE CHARLES S.

Old Republic International Corp director Arnold Steiner on the 13-06-2018 unloaded a total of 40,000 shares of the stock exchange listed company with a total value of about $846,550 U.S. Dollars. This is exactly based on the average stock price value of $21.2 U.S. Dollars. Arnold Steiner now owns 661,237 shares of the Firm. The dated 13-06-2018 transaction’s filing that was filed with the Security and Exchange Commission is ready for you here.

Among 2 analysts covering Old Republic Intl (NYSE:ORI), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Old Republic Intl had 2 analyst reports since October 30, 2017 according to SRatingsIntel. As per Monday, February 12, the company rating was upgraded by JMP Securities. On Monday, October 30 the stock rating was upgraded by Raymond James to “Strong Buy”.

More news for Old Republic International Corporation (NYSE:ORI) were recently published by: Finance.Yahoo.com, which released: “Only 3 Days Left To Cash In On Old Republic International Corporation (NYSE:ORI) Dividend, Should You Buy?” on June 02, 2018. Seekingalpha.com‘s article titled: “Old Republic promotes Smiddy to president, COO” and published on May 16, 2018 is yet another important article.

Old Republic International Corporation, through its subsidiaries, engages in the insurance underwriting and related services business primarily in the United States and Canada. The company has market cap of $6.35 billion. It operates through three divisions: General Insurance Group, Title Insurance Group, and the Republic Financial Indemnity Group Run-off Business. It has a 13.54 P/E ratio. The General Insurance Group segment offers automobile extended warranty, aviation, commercial automobile, commercial multi-peril, general liability, home warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, directors and officers, fidelity, guaranteed asset protection, and surety.

Among 7 analysts covering CytoSorbents (NASDAQ:CTSO), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CytoSorbents has $14.0 highest and $7 lowest target. $11.36’s average target is 1.43% above currents $11.2 stock price. CytoSorbents had 16 analyst reports since October 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by Maxim Group on Wednesday, July 5. Maxim Group initiated the stock with “Buy” rating in Tuesday, May 24 report. The stock of Cytosorbents Corporation (NASDAQ:CTSO) earned “Buy” rating by Maxim Group on Monday, July 17. H.C. Wainwright maintained the shares of CTSO in report on Tuesday, September 26 with “Buy” rating. Maxim Group maintained the shares of CTSO in report on Tuesday, August 8 with “Buy” rating. The stock has “Buy” rating by H.C. Wainwright on Friday, March 9. The firm earned “Buy” rating on Friday, October 7 by B. Riley & Co. The firm has “Buy” rating by WBB Securities given on Thursday, October 29. The stock of Cytosorbents Corporation (NASDAQ:CTSO) earned “Buy” rating by Cowen & Co on Thursday, March 8. The stock has “Buy” rating by Aegis Capital on Wednesday, October 26.

CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent, porous polymer technology. The company has market cap of $336.48 million. The Company’s principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; adjunctive therapy in other critical care applications; prevention and treatment of post-operative complications of cardiopulmonary bypass surgery; and prevention and treatment of organ dysfunction in brain-dead organ donors to increase the number and quality of viable organs harvested from donors. It currently has negative earnings. The firm also provides VetResQ device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.

Since January 8, 2018, it had 0 buys, and 10 selling transactions for $819,400 activity. On Wednesday, February 21 BLOCH KATHLEEN P. sold $80,000 worth of Cytosorbents Corporation (NASDAQ:CTSO) or 10,000 shares. The insider Capponi Vincent sold $43,614.

Another recent and important Cytosorbents Corporation (NASDAQ:CTSO) news was published by Prnewswire.com which published an article titled: “CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference” on June 04, 2018.

Cytosorbents Corporation (NASDAQ:CTSO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: